
Sign up to save your podcasts
Or


Audio roundup of selected biopharma industry content from Scrip over the business week ended May 29, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools.
This time – can GLP-1s help in cancer; Novartis on its cardiovascular strategy; Lilly’s retatrutide looks promising in obesity; Lilly’s raises cell and gene therapy bet; and the business impact of China’s new data protections.
By Norstella4.1
2828 ratings
Audio roundup of selected biopharma industry content from Scrip over the business week ended May 29, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools.
This time – can GLP-1s help in cancer; Novartis on its cardiovascular strategy; Lilly’s retatrutide looks promising in obesity; Lilly’s raises cell and gene therapy bet; and the business impact of China’s new data protections.

1,290 Listeners

1,713 Listeners

4,420 Listeners

406 Listeners

154 Listeners

1,036 Listeners

837 Listeners

337 Listeners

1,320 Listeners

6,097 Listeners

1,281 Listeners

34 Listeners

678 Listeners

21 Listeners

170 Listeners